Serina Therapeutics Chief Scientific Officer Randall Moreadith Reports Disposal of Common Shares

Reuters
2025.10.14 17:17
portai
I'm PortAI, I can summarize articles.

Randall Moreadith, Chief Scientific Officer of Serina Therapeutics Inc., has reported the disposal of common shares in the company, as per a recent SEC filing. The full filing is accessible through the provided link. This news brief was generated by Public Technologies and is intended for informational purposes only, not as financial or legal advice. The original content was published by Serina Therapeutics via EDGAR on October 14, 2025.

Randall Moreadith, Chief Scientific Officer of Serina Therapeutics Inc., reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001301120-25-000007), on October 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.